Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Only a small subset of the listed statements is assessable against the provided label excerpts (boxed warning and §§5.1/5.2). Several statements are general GI-management and risk-factor claims that are not supported by the supplied excerpts, and the overall response includes many assertions beyond what was provided.
Category Scores
Accurate Statements
CALDOLOR (ibuprofen injection) is associated with serious cardiovascular thrombotic events (including myocardial infarction and stroke) and serious gastrointestinal bleeding/ulceration/perforation that can be fatal.
Supported by label Boxed Warning and §§5.1 (CV thrombotic events) and 5.2 (GI bleeding/ulceration/perforation).
Unsupported Statements
NSAIDs reduce prostaglandins, which helps protect the stomach lining.
Not supported by the provided label excerpts.
Ibuprofen can be taken without food for many people.
Not supported by the provided label excerpts.
Taking ibuprofen on an empty stomach can irritate the stomach lining more easily; can increase the chance of stomach pain, nausea, heartburn, or indigestion.
Not supported by the provided label excerpts (which discuss serious GI adverse events, not these specific symptom comparisons).
Taking ibuprofen on an empty stomach may contribute to ulcers or bleeding in higher-risk people.
Not supported by the provided label excerpts.
People often report stomach-related side effects sooner or more strongly when taking ibuprofen without food.
Not supported by the provided label excerpts.
Stomach-related side effects more likely when taking ibuprofen without food include burning or stomach pain, nausea, reflux/heartburn, and indigestion.
Not supported by the provided label excerpts.
Signs of serious stomach injury include vomiting blood, black/tarry stools, or severe worsening abdominal pain.
Not supported by the provided label excerpts.
Taking ibuprofen with food or right after a snack can reduce irritation.
Not supported by the provided label excerpts.
Food generally helps more than just fluids for reducing ibuprofen irritation.
Not supported by the provided label excerpts.
Milk may reduce irritation for some people, but it is not as reliable as taking ibuprofen with a proper meal or snack.
Not supported by the provided label excerpts.
Antacids can sometimes relieve symptoms like heartburn from ibuprofen.
Not supported by the provided label excerpts.
Antacids do not eliminate the underlying ulcer/bleeding risk from NSAIDs in higher-risk patients.
Not supported by the provided label excerpts.
Extra caution is warranted if the person has a history of stomach ulcers, gastritis, or GI bleeding.
Only partially supported: label excerpts mention a prior history of peptic ulcer disease and/or GI bleeding at greater risk, but gastritis is not explicitly supported in the provided excerpts.
Extra caution is warranted if the person takes blood thinners such as warfarin; antiplatelets such as clopidogrel.
Not supported by the provided label excerpts.
Extra caution is warranted if the person drinks frequent alcohol.
Not supported by the provided label excerpts.
Extra caution is warranted if the person takes other NSAIDs, increasing dose-related risk.
Not supported by the provided label excerpts.
Extra caution is warranted if the person has significant kidney disease; uncontrolled heart failure; certain bleeding disorders.
Not supported by the provided label excerpts.
Acetaminophen generally does not irritate the stomach the way NSAIDs do.
Not supported by the provided label excerpts.
Acetaminophen has safety limits, especially for liver disease or heavy alcohol use.
Not supported by the provided label excerpts.
If stronger pain relief or NSAID therapy due to inflammation is needed, a clinician may recommend an approach that reduces GI risk.
Not supported by the provided label excerpts.
Ibuprofen should not be combined with multiple NSAIDs.
Not supported by the provided label excerpts.
Contradictions
Important Omissions
The provided response includes many detailed practical claims (e.g., food/empty-stomach symptom likelihood, use of milk/antacids, and specific caution lists) but does not anchor them to the supplied label sections; the label excerpts provided focus on serious CV and GI risks rather than these management specifics.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
While the core boxed-warning claim about serious CV and GI fatal events is supported, many additional operational/symptom-management assertions are not supported by the supplied label excerpts, which could mislead about risk mitigation or interpretation of seriousness.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Most statements (especially those about taking without food, symptom probabilities, antacids/milk, and multiple specific caution conditions) are not supported by the provided prescribing-information excerpts.
Suggested Improvement
Limit claims to what is explicitly supported by the provided label excerpts (boxed warning and §§5.1/5.2) when evaluating serious CV thrombotic and GI bleeding/ulceration/perforation risk, and avoid adding unverified symptom-management or risk-factor specifics not present in the supplied text.